This user has not added any information to their profile yet.
Company Profile
Introduction to Astellas Pharma Vietnam LLC.
Astellas Pharma was established in 2005 through the merger of two long-standing Japanese pharmaceutical companies, Yamanouchi and Fujisawa, both with over 120 years of history. Today, Astellas operates in more than 70 countries and has reached over 159 million patients across 103 countries through breakthrough therapies that improve quality of life. The company is headquartered in Tokyo, Japan, and owns 6 global research centers, a major manufacturing facility, and a network of subsidiaries and representative offices worldwide.
In Vietnam, Astellas products have been available since 2006. In 2021, Astellas Pharma Vietnam LLC. was officially established, marking a long-term investment commitment to the Vietnamese market. Astellas pursues a strategic vision of transforming innovative pharmaceutical discoveries into real value for patients.
The company offers a diverse portfolio in Vietnam, covering organ transplantation, oncology, and urology. It is expanding into advanced therapeutic areas such as specialized cancer care, health, and ophthalmology, demonstrating its long-term commitment to improving the quality of life for Vietnamese people.
Astellas focuses on enhancing supply capabilities, raising disease awareness, and ensuring timely patient access to new therapies. The company also builds a high-quality workforce, nurtures talent, and fosters close collaboration with healthcare institutions and professional associations to improve public health outcomes.
With a sustainable development orientation, Astellas is committed to supporting the growth of healthcare sector.
Company Information
Company Description
Introduction to Astellas Pharma Vietnam LLC.
Astellas Pharma was established in 2005 through the merger of two long-standing Japanese pharmaceutical companies, Yamanouchi and Fujisawa, both with over 120 years of history. Today, Astellas operates in more than 70 countries and has reached over 159 million patients across 103 countries through breakthrough therapies that improve quality of life. The company is headquartered in Tokyo, Japan, and owns 6 global research centers, a major manufacturing facility, and a network of subsidiaries and representative offices worldwide.
In Vietnam, Astellas products have been available since 2006. In 2021, Astellas Pharma Vietnam LLC. was officially established, marking a long-term investment commitment to the Vietnamese market. Astellas pursues a strategic vision of transforming innovative pharmaceutical discoveries into real value for patients.
The company offers a diverse portfolio in Vietnam, covering organ transplantation, oncology, and urology. It is expanding into advanced therapeutic areas such as specialized cancer care, health, and ophthalmology, demonstrating its long-term commitment to improving the quality of life for Vietnamese people.
Astellas focuses on enhancing supply capabilities, raising disease awareness, and ensuring timely patient access to new therapies. The company also builds a high-quality workforce, nurtures talent, and fosters close collaboration with healthcare institutions and professional associations to improve public health outcomes.
With a sustainable development orientation, Astellas is committed to supporting the growth of healthcare sector.
Business Category
Country
Number of Employees in Vietnam
Company Name
Address
Telephone
2nd Address
2nd Telephone
Website
Log in as a member to access the details. Not a member? Contact our Membership team at (84-28) 3827 2715 ext 105 or membership@eurochamvn.org
This user has not added any information to their profile yet.
Company Profile
Introduction to Astellas Pharma Vietnam LLC.
Astellas Pharma was established in 2005 through the merger of two long-standing Japanese pharmaceutical companies, Yamanouchi and Fujisawa, both with over 120 years of history. Today, Astellas operates in more than 70 countries and has reached over 159 million patients across 103 countries through breakthrough therapies that improve quality of life. The company is headquartered in Tokyo, Japan, and owns 6 global research centers, a major manufacturing facility, and a network of subsidiaries and representative offices worldwide.
In Vietnam, Astellas products have been available since 2006. In 2021, Astellas Pharma Vietnam LLC. was officially established, marking a long-term investment commitment to the Vietnamese market. Astellas pursues a strategic vision of transforming innovative pharmaceutical discoveries into real value for patients.
The company offers a diverse portfolio in Vietnam, covering organ transplantation, oncology, and urology. It is expanding into advanced therapeutic areas such as specialized cancer care, health, and ophthalmology, demonstrating its long-term commitment to improving the quality of life for Vietnamese people.
Astellas focuses on enhancing supply capabilities, raising disease awareness, and ensuring timely patient access to new therapies. The company also builds a high-quality workforce, nurtures talent, and fosters close collaboration with healthcare institutions and professional associations to improve public health outcomes.
With a sustainable development orientation, Astellas is committed to supporting the growth of healthcare sector.
Company Information
